LIM
NVO

Longfellow Investment Management’s Novo Nordisk NVO Stock Holding History

Longfellow Investment Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-49,800
Closed -$2.53M – 266
2025
Q4 		$2.53M Hold
49,800
– – 0.57% 25
2025
Q3 		$2.76M Buy
49,800
+21,543
+76% +$1.26M 0.66% 27
2025
Q2 		$1.95M Buy
+28,257
New +$1.92M 0.48% 32

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Longfellow Investment Management's NVO Position: Q1 2026 in Review

Longfellow Investment Management sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 49,800 shares — an estimated $2.53M sold.

Longfellow Investment Management first reported a position in NVO in Q2 2025 and held it in 3 quarters. The position peaked at $2.76M in Q3 2025. 1,277 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Longfellow Investment Management reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
  • Longfellow Investment Management sold 49,800 Novo Nordisk shares in Q1 2026, an estimated $2.53M.
  • Longfellow Investment Management first reported a position in Novo Nordisk in Q2 2025 and held it in 3 quarters.
  • Longfellow Investment Management's Novo Nordisk position peaked at $2.76M in Q3 2025.
  • 1,277 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Longfellow Investment Management's 13F filing for Q1 2026, filed 12 May 2026.